TRS ACCESS Network

Treatment-resistant Schizophrenia: Advocacy, Clinical Consultation, Education, Support Service

Improving patient outcomes in treatment-resistant schizophrenia through advocacy, sharing clinical expertise, providing education and consultation to healthcare professionals, and supporting clinics in delivering evidence-based treatments.

Learn More Contact Us

About TRS ACCESS

Building a network for accessible clozapine treatment

Our Mission

The TRS ACCESS program at Massachusetts General Hospital is dedicated to improving outcomes for people with treatment-resistant schizophrenia by expanding timely access to effective treatments, particularly clozapine and long-acting injectable antipsychotics. Our goal is to build a robust network of clinics capable of safely providing these highly effective yet underutilized treatments. Through clinician support, expert guidance, targeted education, and practical resources, we empower healthcare systems to deliver high-quality care at the earliest possible stage, transforming the lives of individuals affected by treatment-resistant schizophrenia.

Brain imaging research
30%
of patients with schizophrenia have treatment-resistant schizophrenia
5%
of patients with schizophrenia currently receive clozapine treatment

Video Coming Soon

What Does TRS ACCESS Stand For?

Abigail Donovan, MD explains our mission

Learn about the comprehensive approach behind TRS ACCESS and how we're helping clinicians become capable of prescribing clozapine safely and effectively for patients with treatment-resistant schizophrenia.

Video Coming Soon

Why Outcomes Matter?

Abigail Donovan, MD explains the importance of patient outcomes

Understanding the critical importance of measuring and improving patient outcomes in treatment-resistant schizophrenia, and how evidence-based approaches can transform lives and healthcare delivery.

Our Team

Expert clinicians dedicated to TRS ACCESS services

Oliver Freudenreich

Oliver Freudenreich, MD

Co-director, MGH Psychosis Clinical and Research Program

Oliver Freudenreich directs the TRS ACCESS program and leads our consultation service, providing expert guidance to clinicians managing complex cases and supporting clinicians to become capable of prescribing clozapine safely and effectively.

Program Director Consultation TRS Expert
Abigail Donovan

Abigail Donovan, MD

Director of Clinical Services, MGH Psychosis Clinical and Research Program

Abigail Donovan specializes in the early detection and treatment of schizophrenia in adolescents and adults, with a focus on outcome-based care and quality improvement initiatives.

Clinical Director Early Psychosis Education
Carol Lim

Carol Lim, MD, MPH

Medical Director, MGH Clozapine Clinic

Carol Lim serves as the medical director of our Clozapine Clinic and leads educational initiatives to help other healthcare systems establish safe and effective clozapine monitoring programs.

Medical Director Clozapine Specialist
Sarah Maclaurin

Sarah Maclaurin, PMHNP-BC

Psychiatric Nurse Practitioner & LAI Specialist

Sarah provides expert clinical care and specializes in long-acting injectable antipsychotic medications, offering consultation and training to healthcare providers.

Nurse Practitioner LAI Specialist
Cheryl Foo

Cheryl Foo, PhD

Clinical Psychologist & Implementation Specialist

Cheryl Foo leads implementation efforts to help clinicians and healthcare systems become capable of prescribing clozapine and long-acting injectables safely and effectively.

Clinical Psychologist Implementation
Marta Hernandez

Marta Hernandez

Program Coordinator

Marta coordinates program activities and provides administrative support to ensure seamless patient care and program operations.

Program Coordinator
Leah Namey

Leah Namey, MPH

Program Manager

Leah manages program operations and oversees quality improvement initiatives within the TRS ACCESS program.

Program Manager

Our Services

Comprehensive support for clozapine treatment implementation

Clinical Consultation

Expert consultation for clinicians managing complex cases of difficult to treat psychosis, providing guidance on diagnosis, treatment planning, and clozapine initiation.

Video Coming Soon

Oliver Freudenreich, MD on consultation services

Learn More

Clozapine Clinic

Our MGH Clozapine Clinic specializes in identifying people who need clozapine and how to initiate and manage treatment. We offer support to other clinics and clinicians to help them prescribe clozapine safely and effectively.

Video Coming Soon

Carol Lim, MD on clozapine clinic services

Learn More

Long-Acting Injectable Services

Training and consultation on long-acting injectable antipsychotic medications, helping clinicians optimize medication adherence and improve treatment outcomes.

Video Coming Soon

Sarah Maclaurin, PMHNP-BC on LAI expertise

Learn More

Program Implementation

Implementation support to help healthcare systems and clinicians become capable of prescribing clozapine safely and effectively, including staff training, workflow development, and ongoing support.

Video Coming Soon

Cheryl Foo, PhD on program implementation

Learn More

Resources

Educational materials and publications from our faculty

Books by Our Faculty

Psychotic Disorders: A Practical Guide, Second Edition

Psychotic Disorders: A Practical Guide

by Oliver Freudenreich, MD

Second Edition - A comprehensive guide to understanding and treating psychotic disorders in clinical practice.

Facing Serious Mental Illness

Facing Serious Mental Illness

by Oliver Freudenreich, MD, Corinne Cather, PhD, and Theodore A. Stern, MD

A guide for patients and families dealing with serious mental illness.

Substance Use and the Acute Psychiatric Patient

Substance Use and the Acute Psychiatric Patient

by Abigail L. Donovan, MD and Suzanne A. Bird, MD

Emergency Management - A comprehensive guide for managing substance use in psychiatric emergencies.

Suicide by Security Blanket

Suicide by Security Blanket

by Laura M. Prager, MD and Abigail Louise Donovan, MD

And Other Stories from the World of Emergency Psychiatry.

Educational Videos

Secondary Psychosis

Oliver Freudenreich, MD discusses secondary psychosis and differential diagnosis considerations.

Oliver Freudenreich Diagnosis

Schizophrenia: Causes, Symptoms, Risk Factors

Abigail Donovan, MD explains the spectrum of schizophrenia, covering causes, symptoms, and treatment approaches.

Abigail Donovan Education

Treatment-Resistant Schizophrenia Overview

Educational presentation on treatment-resistant schizophrenia and clozapine therapy approaches.

TRS Clozapine

Clinical Research in Psychosis

Research seminar discussing current clinical research initiatives in psychosis treatment and management.

Research Clinical

Contact TRS ACCESS

Get in touch with our specialized team

Address

151 Merrimac St, Suite 401
Boston, MA 02114

Phone

617-643-1175

Email

mghtrsaccess@gmail.com

Send us a message